Thought is a good time to pull this thread up for a little update. CUV has received FDA approval this morning Sydney time. The SP has been shortened for quite a while now after almost hitting $40 a short while ago. Reading the FDA's own publication of the approval is definitely worth a read.
What this means for PAR: A drug which undoubtedly helps people big times but which a much smaller group of customers is moving on strong. With a much larger potential customer base in every market this continues to look like a no brainer for the patient holder.
For anyone who has invested in CUV as well as PAR, congratulations!
Thought is a good time to pull this thread up for a little...
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $76.98M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.5¢ | 21.0¢ | $242.2K | 1.102M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16020 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 310000 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |